Share

Save

LaryngOscoPy for neonaTal and Infant aIrway Management wIth Supplemental oxygEn

NOT_YET_RECRUITING

Tracheal intubation in neonates can be technically challenging, even for experienced pediatric anesthesiologists, with a high first-attempt success rate crucial to ensure safety. Intubation, while life-saving for children with circulatory shock or respiratory failure, carries risks of severe desaturation that can lead to hypoxic encephalopathy, cardiac arrest, or death. Neonates, especially, are prone to hypoxemia due to high oxygen consumption, low functional residual capacity, small closing capacity, and increased risk of airway collapse, which is exacerbated under anesthesia and neuromuscular paralysis.

Rapid desaturation occurs after cessation of ventilation, with neonates facing shorter apnea times before desaturation. Studies show that about two-thirds of neonates undergoing non-emergency nasotracheal intubation experience desaturation (SpO₂ \<80% for over 60 seconds), although low-flow oxygen supplementation (0. 2 L/kg/min) can extend safe apnea time.

This study aims to investigate apneic oxygenation with VL (using Miller or Macintosh blades size 0 or 1) in operating rooms or intensive care units. We hypothesize that supplemental oxygen and standardized VL use will improve first-pass success rates and reduce adverse events.

info
Simpliy with AI

Study details:

Eligible children will undergo preparation for intubation following the local Standard Operating Procedures (SOPs) of the pediatric anesthesia departments. Mandatory monitoring includes pulse oximetry (SpO2), heart rate (HR), and non-invasive blood pressure (NIBP). Anesthesia Induction:.

Where feasible, all children enrolled in this protocol will be pre-oxygenated for one minute prior to induction of anesthesia using a face mask with FiO2 1. 0 and a flow rate of 6-10 L/min. Anesthesia induction for tracheal intubation will involve a combination of sedative or hypnotic drugs, opioids, and a non-depolarizing muscle relaxant.

Required Medications (per protocol):. Neuromuscular Blocking Agent (NMBA): One of the following-Rocuronium 0. 5-1 mg/kg, Cis-Atracurium 0.

2-0. 5 mg/kg, Atracurium 0. 5 mg/kg, Vecuronium 0.

1 mg/kg, Mivacurium 0. 2-0. 3 mg/kg, or Succinylcholine 2 mg/kg.

Hypnotic Agent: One or more of the following-Thiopentone 4-7 mg/kg, Ketamine 0. 5-2 mg/kg, Propofol 1-4 mg/kg, Midazolam 0. 5-1 mg/kg, or Sevoflurane up to 8%.

Optional Medications: An opioid and/or anticholinergic may be administered at the anesthetist's discretion. Pre-Intubation Preparation:. Following induction of anesthesia and administration of an NMBA, bag-mask ventilation with FiO2 1.

0 (flow rate of 6-10 L/min) will be performed for 60 seconds until apnea occurs. To facilitate airway management, complete neuromuscular blockade will be confirmed using train-of-four (TOF) monitoring. Oxygen administration, laryngoscopy, and tracheal intubation will follow.

Intubation Procedure:. Oxygen administration during intubation is mandatory for all participants and will be randomized as follows:. Apneic Oxygenation: Oxygen will be administered at 1 L/kg/min via a conventional nasal cannula.

Laryngoscopy and tracheal intubation will proceed following apneic oxygenation. Standard Care: No apneic oxygenation will be administered. After induction, laryngoscopy and tracheal intubation will proceed without additional oxygen support.

Tube Selection:. For premature neonates under 1 kg, an uncuffed tube with an internal diameter (ID) of 2. 5 will be used.

For premature neonates and newborns between 1 kg and 3. 0 kg, an uncuffed tube with ID 3. 0 will be used.

For babies over 3. 0 kg up to 8 months, a cuffed tube with ID 3. 0 or an uncuffed tube with ID 3.

5 will be used. For infants aged 8 to 12 months, a cuffed tube with ID 3. 5 or an uncuffed tube with ID 4.

0 will be used. Oxygen delivery will follow the assigned randomization group, either via conventional nasal cannula (apneic oxygenation) or standard care. Laryngoscope Blade Selection:.

For children weighing less than 1 kg, a Miller or Macintosh blade, size No. 0, will be used. In cases of unexpected difficult intubation, the difficult airway algorithm will be applied.

After an unsuccessful first intubation attempt with the assigned flow rate, clinical judgment will guide the intubating physician on whether to repeat the attempt with the same flow rate or to modify the flow rate, blade size, or type of laryngoscope. A maximum of four intubation attempts will be allowed, with the final attempt performed by the most experienced physician present. Additional tools, such as a stylet or bougie, may be used at any stage.

If intubation remains unsuccessful, the difficult airway algorithm will be applied, and a supraglottic airway (SGA) device will be inserted.

info
Simplify with AI

Eligibility criteria

Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.

Inclusion criteria

  • Pediatric patients requiring oral or nasal tracheal intubation for elective, semi-elective, or urgent surgical and non-surgical procedures.
  • Neonates and infants up to 52 weeks post-conceptual age.
  • Written informed consent provided by legal guardians prior to the intervention.
  • Exclusion criteria

  • Prediction of difficult intubation based on physical examination or a history of previous difficult intubation.
  • Requirement for an alternative technique to direct laryngoscopy to secure the airway.
  • Specific conditions, such as congenital heart disease requiring FiO₂ < 1.0, or cardiopulmonary collapse necessitating advanced life support and intubation for emergency surgical or non-surgical interventions.
  • info
    Simplify with AI

    Eligibility

    Age eligible for study : 1 and older

    Healthy volunteers accepted : No

    Gender eligible for study: All

    Things to know

    Study dates

    Study start: 2024-12-01

    Primary completion: 2026-06-01

    Study completion finish: 2026-12-01

    study type

    Study type

    PREVENTION

    phase

    Phase

      NA

    trial

    Trial ID

    NCT06683599

    Intervention or treatment

    PROCEDURE: Apneic oxygenation

    Conditions

    • Difficult Airway
    • Difficult Airway Intubation
    • Neonate
    Image related to Difficult Airway
    • Condition: Difficult Airway, Difficult Airway Intubation and more

    • PROCEDURE: Apneic oxygenation

    • Perth, Western Australia, Australia

    • Sponsor: Vinícius C Quintão, MD, MSc, PhD

    Find a site

    Closest Location:

    Perth Children's Hospital

    Research sites nearby

    Select from list below to view details:

    • Perth Children's Hospital

      Perth, Western Australia, Australia

    Loading...

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    How is the study designed?

    Participant Group/ArmIntervention/Treatment
    NO_INTERVENTION: Standard of care
    • Tracheal intubation performed with a video laryngoscope with Miller-blade or Macintosh-blade size No. 0 or No. 1 without apneic oxygenation.
    Not specified
    EXPERIMENTAL: Apneic oxygenation
    • 1 L/kg/min FiO2 1.0 low-flow nasal supplemental oxygen with conventional nasal cannula during tracheal intubation performed with a video laryngoscope with Miller-blade or Macintosh-blade size No. 0 or No. 1.
    PROCEDURE: Apneic oxygenation
    • 1 L/kg/min FiO2 1.0 low-flow nasal supplemental oxygen with conventional nasal cannula during tracheal intubation performed with a video laryngoscope with Miller-blade or Macintosh-blade size No. 0 or No. 1.

    What is the study measuring?

    Primary outcome

    Primary Outcome MeasurePrimary Outcome DescriptionPrimary Outcome Time Frame
    First-attempt success rateThe primary study outcome is to evaluate the first attempt success rate of oral tracheal intubation without desaturation (\< 90%) and/or bradycardia (\< 100 bpm) with video laryngoscope with supplemental oxygen (apneic oxygenation) vs without supplemental oxygen in infants up to 52 weeks postconceptual age. A successful tracheal intubation (ETI) attempt is defined as successful placement of a tracheal tube in the trachea, confirmed by visualization of the tube passing the vocal cords, a waveform capnography suggesting correct ETT placement and auscultation of breath sounds in the lungsFrom randomization until up to 15 minutes

    Secondary outcome

    Secondary Outcome MeasureSecondary Outcome DescriptionSecondary Outcome Time Frame
    Desaturation rateOccurrence and duration of moderate and severe desaturation (SpO2 \< 90% and SpO2 \< 80%), with or without bradycardia, during intubation.From randomization until up to 15 minutes
    Overall number of intubation attemptsThe overall number of intubation attempts.From randomization until up to 15 minutes
    Time to intubationTime required for intubation (in seconds, defined from the first introduction of laryngoscope between the lips till successful lung ventilation defined as positive capnography).From randomization until up to 5 minutes
    Respiratory complications rateRespiratory complications and complications of airway management within the first 24 hours, such as airway injury, cardiopulmonary resuscitation, bleeding, aspiration of gastric contents, post-extubation stridor, laryngospasm, bronchospasm, need for High Flow Nasal Oxygen (if not preoperatively on oxygen), need for low flow nasal oxygen (if not preoperatively on oxygen) or need for re-intubation will be recorded. Respiratory complications are defined as the need for re-intubation after being extubated, persistent stridor (even if oxygen is not required), respiratory failure, the occurrence of pneumothorax, or the need for any additional diagnostic examination following respiratory problems (i.e., bronchoscopy, radiology).From randomization until up to 24 hours
    First EtCO2 after successful intubationValue in mmHg or kPa of the first reliable etCO2 reading after successful intubationFrom randomization until up to 10 minutes
    Cormack-Lehane scoreThe Cormack-Lehane score, classified as 1, 2a, 2b, 3, or 4, recorded at each laryngoscopy attemptFrom randomization until up to 5 minutes
    The need for additional devicesThe need for additional devices used at any step of intubationFrom randomization until up to 5 minutes
    Duration of severe desaturationDuration of moderate and severe desaturation (SpO2 \< 80%), with or without bradycardia, during intubationFrom randomization until up to 15 minutes
    Percentage of Glottic Opening (POGO) scorePercentage of Glottic Opening (POGO) score recorded at each laryngoscopy attempt, ranging from 0% to 100%, with 100% indicating the best possible glottic viewFrom randomization until up to 5 minutes

    Frequently Asked Questions

    Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol

    No questions submitted. Be the first to ask a question!

    You may be eligible to participate in this trial based on your search.Apply for study
    Are you running this trial? If you're a clinic or sponsor, you can claim this study.Claim this trial

    References

    Clinical Trials Gov: LaryngOscoPy for neonaTal and Infant aIrway Management wIth Supplemental oxygEn

    Other trails to consider

    Top searched conditions